Brevibloc (General Injectables & Vaccines)


Welcome to the PulseAid listing for the Brevibloc drug offered from General Injectables & Vaccines. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: General Injectables & Vaccines
NON-PROPRIETARY NAME: Brevibloc
SUBSTANCE NAME: ESMOLOL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-07-01
END MARKETING DATE: 0000-00-00


Brevibloc HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBrevibloc from General Injectables & Vaccines
LABELER NAME: General Injectables & Vaccines
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2010-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52584-115_b8c20cd3-e4a3-4296-8b41-e3ab122e863f
PRODUCT NDC: 52584-115
APPLICATION NUMBER: NDA019386

Other ESMOLOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Esmolol Hydrochloride
AuroMedics Pharma LLCEsmolol Hydrochloride
Baxter Healthcare CorporationBrevibloc
Cardinal HealthEsmolol Hydrochloride
Fresenius Kabi USA, LLCEsmolol Hydrochloride
General Injectables & VaccinesBrevibloc
General Injectables & Vaccines, IncEsmolol
General Injectables and Vaccines, Inc.Esmolol Hydrochloride
Mylan Institutional LLCEsmolol Hydrochloride
West Ward Pharmaceutical CorporationEsmolol Hydrochloride